Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $20,685 | 12 | 81.9% |
| Travel and Lodging | $2,050 | 6 | 8.1% |
| Food and Beverage | $1,546 | 17 | 6.1% |
| Unspecified | $965.00 | 2 | 3.8% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $7,906 | 9 | $0 (2024) |
| PFIZER INC. | $5,230 | 5 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $4,139 | 9 | $0 (2024) |
| GlaxoSmithKline, LLC. | $3,701 | 2 | $0 (2024) |
| ABBVIE INC. | $2,300 | 5 | $0 (2024) |
| NS Pharma, Inc. | $984.03 | 4 | $0 (2023) |
| Eli Lilly and Company | $965.00 | 2 | $0 (2020) |
| Radius Health, Inc. | $20.95 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,228 | 16 | AstraZeneca Pharmaceuticals LP ($3,674) |
| 2023 | $5,193 | 12 | Amgen Inc. ($2,241) |
| 2022 | $4,950 | 1 | Amgen Inc. ($4,950) |
| 2020 | $30.60 | 1 | Eli Lilly and Company ($30.60) |
| 2019 | $9,844 | 7 | PFIZER INC. ($5,230) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $465.00 | General |
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,395.00 | General |
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | Cash or cash equivalent | $439.45 | General |
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | Cash or cash equivalent | $67.10 | General |
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $99.96 | General |
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $130.90 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/15/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $115.21 | General |
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $131.19 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 10/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: IMMUNOLOGY | ||||||
| 07/11/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: IMMUNOLOGY | ||||||
| 05/13/2024 | Amgen Inc. | TAVNEOS (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Inflammation | ||||||
| 05/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: IMMUNOLOGY | ||||||
| 04/25/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $115.19 | General |
| 04/10/2024 | Radius Health, Inc. | — | Food and Beverage | In-kind items and services | $20.95 | General |
| 01/18/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Consulting Fee | Cash or cash equivalent | $930.00 | General |
| Category: Respiratory | ||||||
| 12/22/2023 | Amgen Inc. | TAVNEOS (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Inflammation | ||||||
| 12/08/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Consulting Fee | Cash or cash equivalent | $465.00 | General |
| Category: Respiratory | ||||||
| 11/20/2023 | Amgen Inc. | TAVNEOS (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Inflammation | ||||||
| 11/13/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $47.65 | General |
| Category: Inflammation | ||||||
| 11/06/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.78 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $94.17 | General |
| Category: Inflammation | ||||||
| 08/25/2023 | NS Pharma, Inc. | — | Travel and Lodging | In-kind items and services | $418.58 | General |
| 08/25/2023 | NS Pharma, Inc. | — | Travel and Lodging | In-kind items and services | $273.45 | General |
| 08/25/2023 | NS Pharma, Inc. | — | Food and Beverage | In-kind items and services | $192.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 3 STUDY OF BARICITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS | Eli Lilly and Company | $965.00 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 51 | 68 | $23,287 | $6,375 |
| 2022 | 1 | 23 | 23 | $2,605 | $1,514 |
| 2021 | 2 | 59 | 68 | $8,535 | $5,085 |
| 2020 | 2 | 52 | 65 | $7,664 | $4,820 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 22 | 36 | $9,324 | $2,576 | 27.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 15 | 15 | $7,350 | $2,043 | 27.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 14 | 17 | $6,613 | $1,756 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 23 | $2,605 | $1,514 | 58.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 29 | 33 | $3,845 | $2,546 | 66.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 19 | 21 | $2,395 | $1,345 | 56.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 14 | $2,295 | $1,194 | 52.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 33 | 44 | $5,778 | $3,516 | 60.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 19 | 21 | $1,886 | $1,304 | 69.1% |
About Dr. Kathleen Maksimowicz-Mckinnon, DO
Dr. Kathleen Maksimowicz-Mckinnon, DO is a Specialist healthcare provider based in Detroit, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922072602.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kathleen Maksimowicz-Mckinnon, DO has received a total of $25,246 in payments from pharmaceutical and medical device companies, with $5,228 received in 2024. These payments were reported across 37 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($20,685).
As a Medicare-enrolled provider, Maksimowicz-Mckinnon has provided services to 185 Medicare beneficiaries, totaling 224 services with total Medicare billing of $17,793. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Rheumatology
- Location Detroit, MI
- Active Since 02/17/2006
- Last Updated 08/01/2014
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1922072602
Products in Payments
- XELJANZ (Drug) $5,230
- Tavneos (Drug) $4,950
- TAVNEOS (Drug) $2,642
- RINVOQ (Biological) $2,300
- FASENRA (Biological) $1,395
- SAPHNELO (Biological) $262.09
- BENLYSTA (Biological) $20.88
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Detroit
Muwaffak Abdulhak, M.d, M.D
Specialist — Payments: $659,690
Monte Harvill, Md, MD
Specialist — Payments: $13,209
Dr. Lacesha Brintley, Md, MD
Specialist — Payments: $7,495
Brian Rill, M.d, M.D
Specialist — Payments: $6,817
Dr. Deniz Altinok, Md, MD
Specialist — Payments: $1,411
Ashraf Mohamed, M.d, M.D
Specialist — Payments: $1,116